Do you want to read an article? Please log in or register.
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study
Pleural Diseases
RECOMMENDED
Related content
RECOMMENDED
COPD
Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
Respir Res.
Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A
doi: 10.1186/s12931-018-0951-4.
Pulmonary Fibrosis
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
Lancet Respir Med.
Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N
doi: 10.1016/
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
Lancet Oncol.
Psallidas I, Kanellakis NI, Gerry S, Thézénas ML, Charles PD, Samsonova A, Schiller HB, Fischer R, Asciak R, Hallifax RJ, Mercer R, Dobson M, Dong T, Pavord ID, Collins GS, Kessler BM, Pass HI, Maskell N, Stathopoulos GT, Rahman NM
doi: 10.1016/S1470-
Lung Cancer
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The development and validation of the LNC-PATH score
Lung Cancer.
Balata H, Foden P, Edwards T, Chaturvedi A, Elshafi M, Tempowski A, Teng B, Whittemore P, Blyth KG, Kidd A, Ellames D, Flint LA, Robson J, Teh E, Jones R, Batchelor T, Crosbie P, Booton R, Evison M
doi: 10.1016/j.lungcan.
COMMENTED
Tuberculosis
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study
Lancet Infect Dis.
Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team
doi: 10.1016/
RECOMMENDED
COPD
Predictive value of control of COPD for risk of exacerbations: An international, prospective study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1111/resp.13811.
RECOMMENDED
Asthma
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
Bloom CI, Drake TM, Docherty AB, Lipworth BJ, Johnston SL, Nguyen-Van-Tam JS, Carson G, Dunning J, Harrison EM, Baillie JK, Semple MG, Cullinan P, Openshaw PJM, ISARIC investigators.
doi: 10.1016/S2213-2600(21)00013-8
COMMENTED
CoughPleural Diseases
Pleural manometry in patients with pleural diseases - the usefulness in clinical practice
Respir Med.
Grabczak EM, Krenke R, Zielinska-Krawczyk M, Light RW
doi: 10.1016/j.rmed.2018.01.014.
RECOMMENDED
CoughRespiratory Tract Infection
Molecular epidemiology and clinical impact of rhinovirus infections in adults during three epidemic seasons in 11 European countries (2007-2010)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax.
Zlateva KT, van Rijn AL, Simmonds P, Coenjaerts FEJ, van Loon AM, Verheij TJM, de Vries JJC, Little P, Butler CC, van Zwet EW, Goossens H, Ieven M, Claas ECJ, GRACE Study Group.
doi: 10.1136/thoraxjnl-2019-214317.